Adamed Pharma S.A. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

1986

Location

Poland

Primary Industry

Biotechnology

About

Founded in 1986 and based in Czosnów, Poland, Adamed Pharma S.A., also known as Adamed Group, is a biotechnology company that manufactures over 350 products worldwide. The firm invested has invested 225 million euros in research and development and holds 94 pharmaceutical patents. In 2021, the firm invested in Telemedicin sp. z o.o. series A funding. Adamed Group produces medications that focus on 14 therapeutic areas such as allergology and pulmonology, angiology, antibiotics treatment, diabetology, gastroenterology, gynaecology, cardiology, painkillers, neurology, ophthalmology, dementia medication, psychiatry, rheumatology and urology. The firm's platform also features a drug prescription and its application.

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Medical Supplies, Pharmaceutical Research & Development, Medical Software

Website

www.adamed.com

Verticals

HealthTech, Manufacturing

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.